Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,948 | -56,208 | -34,779 | -15,080 | -32,811 |
| Depreciation Amortization | 112 | 84 | 56 | 28 | 96 |
| Accounts payable and accrued liabilities | -1,309 | -1,714 | -2,041 | 1,889 | 558 |
| Other Working Capital | 19,453 | 8,055 | 2,928 | 2,552 | -6,281 |
| Other Operating Activity | 24,068 | 20,441 | 15,818 | 4,133 | 12,931 |
| Operating Cash Flow | $-41,624 | $-29,342 | $-18,018 | $-6,478 | $-25,507 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,879 | 61,252 | 32,987 | -3,450 | -380,054 |
| PPE Investments | -172 | -38 | -40 | -41 | -22 |
| Investing Cash Flow | $30,707 | $61,214 | $32,947 | $-3,491 | $-380,076 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 235 | 235 | 200 | 83 | 314,335 |
| Financing Cash Flow | $235 | $235 | $200 | $83 | $314,335 |
| Beginning Cash Position | 57,379 | 57,379 | 57,379 | 57,379 | 148,627 |
| End Cash Position | 46,697 | 89,486 | 72,508 | 47,493 | 57,379 |
| Net Cash Flow | $-10,682 | $32,107 | $15,129 | $-9,886 | $-91,248 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,624 | -29,342 | -18,018 | -6,478 | -25,507 |
| Capital Expenditure | -172 | -38 | -40 | -41 | -22 |
| Free Cash Flow | -41,796 | -29,380 | -18,058 | -6,519 | -25,529 |